{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T08:41:46Z","timestamp":1785660106302,"version":"3.56.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA043651"],"award-info":[{"award-number":["K23DA043651"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K24DA038345"],"award-info":[{"award-number":["K24DA038345"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA038800"],"award-info":[{"award-number":["K01DA038800"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ypmed.2019.02.018","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T11:19:44Z","timestamp":1549883984000},"page":"94-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Prescription opioid misuse among middle-aged and older adults in the United States, 2015\u20132016"],"prefix":"10.1016","volume":"121","author":[{"given":"Benjamin H.","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Palamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2019.02.018_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV","volume":"4","author":"American Psychiatric Association","year":"1994"},{"issue":"7","key":"10.1016\/j.ypmed.2019.02.018_bb0010","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1532-5415.2009.02306.x","article-title":"Non-prescription use of pain relievers among middle aged and elderly community adults: National Survey on Drug Use and Health","volume":"57","author":"Blazer","year":"2009","journal-title":"J. Am. Geriatr. Soc."},{"issue":"3","key":"10.1016\/j.ypmed.2019.02.018_bb0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.drugalcdep.2012.11.018","article-title":"National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999\u20132009","volume":"131","author":"Calcaterra","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ypmed.2019.02.018_bb0020","author":"Center for Behavioral Health Statistics and Quality"},{"key":"10.1016\/j.ypmed.2019.02.018_bb0025","author":"Center for Disease Control"},{"key":"10.1016\/j.ypmed.2019.02.018_bb0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drugalcdep.2015.05.010","article-title":"Patterns of major depression and nonmedical use of prescription opioids in the United States","volume":"153","author":"Fink","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.ypmed.2019.02.018_bb0035","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jamapsychiatry.2014.436","article-title":"Emergency department visits by adults for psychiatric medication adverse events","volume":"71","author":"Hampton","year":"2014","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.ypmed.2019.02.018_bb0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health","volume":"167","author":"Han","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ypmed.2019.02.018_bb0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.drugalcdep.2016.11.003","article-title":"Demographic trends of binge alcohol use and alcohol use disorders among older adults in the United States, 2005\u20132014","volume":"170","author":"Han","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ypmed.2019.02.018_bb0050","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","article-title":"Prevalence of marijuana use disorders in the United States between 2001\u20132002 and 2012\u20132013","volume":"72","author":"Hasin","year":"2015","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.ypmed.2019.02.018_bb0055","series-title":"Applied Survey Data Analysis","author":"Heeringa","year":"2010"},{"issue":"2","key":"10.1016\/j.ypmed.2019.02.018_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amepre.2016.02.014","article-title":"Trends in the concomitant prescribing of opioids and benzodiazepines, 2002\u20132014","volume":"51","author":"Hwang","year":"2016","journal-title":"Am. J. Prev. Med."},{"issue":"4","key":"10.1016\/j.ypmed.2019.02.018_bb0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am. J. Prev. Med."},{"issue":"4","key":"10.1016\/j.ypmed.2019.02.018_bb0070","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.4088\/JCP.16m10713","article-title":"National trends in antidepressant, benzodiazepine, and other sedative-hypnotic treatment of older adults in psychiatric and primary care","volume":"78","author":"Maust","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.ypmed.2019.02.018_bb0075","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/j.pain.0000000000001241","article-title":"Sources of opioid medication for misuse in older adults: results from a nationally representative survey","volume":"159","author":"Schepis","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.ypmed.2019.02.018_bb0080","author":"Substance Abuse and Mental Health Services Administration"},{"issue":"9","key":"10.1016\/j.ypmed.2019.02.018_bb0085","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/AJP.0000000000000603","article-title":"Depression effects on long-term prescription opioid use, abuse, and addiction","volume":"34","author":"Sullivan","year":"2018","journal-title":"Clin. J. Pain"},{"issue":"3","key":"10.1016\/j.ypmed.2019.02.018_bb0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.pbb.2011.04.014","article-title":"Powerful behavioral interactions between methamphetamine and morphine","volume":"99","author":"Trujillo","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ypmed.2019.02.018_bb0095","author":"U.S. Food and Drug Administration (FDA)"},{"issue":"4","key":"10.1016\/j.ypmed.2019.02.018_bb0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1152","article-title":"Prevalence of and factors associated with long-term concurrent use of stimulants and opioids among adults with attention-deficit\/hyperactivity disorder","volume":"1","author":"Wei","year":"2018","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.ypmed.2019.02.018_bb0105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11920-013-0436-6","article-title":"The complicated relationship between attention deficit\/hyperactivity disorder and substance use disorders","volume":"16","author":"Zulauf","year":"2014","journal-title":"Curr. Psychiatry Rep."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009174351930057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009174351930057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:03:07Z","timestamp":1758794587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009174351930057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":21,"alternative-id":["S009174351930057X"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2019.02.018","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescription opioid misuse among middle-aged and older adults in the United States, 2015\u20132016","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2019.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}